本页面由Tiger Trade Technology Pte. Ltd.提供服务

Entrada Therapeutics, Inc.

4.86
-0.6400-11.64%
盘后:4.910.0500+1.03%16:39 EDT
成交量:25.52万
成交额:127.41万
市值:1.89亿
市盈率:-1.22
高:5.56
开:5.50
低:4.83
收:5.50
52周最高:16.45
52周最低:4.83
股本:3,882.06万
流通股本:2,554.82万
量比:0.92
换手率:1.00%
股息:- -
股息率:- -
每股收益(TTM):-3.9676
每股收益(LYR):-3.4746
净资产收益率:-54.09%
总资产收益率:-29.20%
市净率:0.81
市盈率(LYR):-1.40

数据加载中...

2024/06/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities